Bionik Laboratories Corp. (OTCMKTS:BNKL) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders
The Annual Meeting of Stockholders (the “Annual Meeting”) of Bionik Laboratories Corp. (the “Company”) was held on March 18, 2019. At the Annual Meeting, the stockholders voted on the following three proposals and cast their votes as described below. The proposals are described in more detail in the Company’s Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on February 11, 2019.
Proposal 1: Election of the eight nominees listed below to serve on the Board of Directors of the Company until the next Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified:
|
Nominee |
For |
Withhold Authority |
| Andre Auberton-Herve | 1,554,173 | 27,425 |
| Eric Dusseux | 1,554,133 | 27,465 |
| Remi Gaston-Dreyfus | 1,555,434 | 26,164 |
| P. Gerald Malone | 1,554,685 | 26,913 |
| Joseph Martin | 1,554,685 | 26,913 |
| Charles Matine | 1,555,017 | 26,581 |
| Audrey Thevenon | 1,555,103 | 26,495 |
| Michal Prywata | 1,554,231 | 27,367 |
Proposal 2: To approve an advisory (non-binding) resolution to approve the compensation of the Company’s named executive officers.
|
For |
Against |
Abstain |
| 1,518,422 | 29,340 | 33,836 |
Proposal 3. To ratify MNP, LLP as the Company’s independent public accountants for the year ending March 31, 2019.
|
For |
Against |
Abstain |
| 1,598,897 | 26,103 | 31,771 |
About Bionik Laboratories Corp. (OTCMKTS:BNKL)
Bionik Laboratories Corp. (Bionik), formerly Drywave Technologies, Inc., is a medical device and robotics company. The Company is focused on providing rehabilitation solutions and developing transformational technologies and solutions to individuals with neurological disorders, specializing in the designing, developing and commercializing of physical rehabilitation technologies, prosthetics and assisted robotic products. It has over three products on the market and approximately three products in various stages of development. The InMotion Systems include the InMotion ARM, InMotion HAND, InMotion Wrist and InMotion ANKLE are designed to provide patent-adaptive therapy in a manner that has been clinically verified to manage neuro-recovery. The Company is also engaged in developing a lower-body exoskeleton, ARKE, which designs to allow paraplegics, as well as other wheelchair users the ability to rehabilitate through walking.
